Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Advanced Pharma Inc.

Advanced Pharma Inc. Recalls

All product recalls associated with Advanced Pharma Inc..

Get alerts for this brand

Recall Summary

Total Recalls

100

Past Year

Class I (Serious)

Most Recent

May 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 21–40 of 100 recalls

Glycopyrrolate Injectable Solution (Advanced Pharma) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAMar 13, 2019Nationwide• Advanced Pharma Inc.

Fentanyl Sodium Chloride (Advanced Pharma) – Incorrect Expiration (2019)

Labeling: Incorrect expiration date.

Class IIModerate

FDAFeb 6, 2019PA• Advanced Pharma Inc.

Oxytocin NS 1000 mL (Advanced Pharma) – Superpotent Drug (2019)

Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Class IIILow

123 4 5

Page 2 of 5Next

FDA

Feb 6, 2019

Nationwide

• Advanced Pharma Inc.

Oxytocin NS 1000 mL (Advanced Pharma) – Superpotent Drug (2019)

Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Class IIILow

FDAFeb 6, 2019Nationwide• Advanced Pharma Inc.

Oxytocin NS 500 mL (Advanced Pharma) – Superpotent Drug (2019)

Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Class IIILow

FDAFeb 6, 2019Nationwide• Advanced Pharma Inc.

HEPERAIN Injectable Solution (Advanced Pharma) – labeling error (2019)

Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)

Class IIModerate

FDAJan 15, 2019TX, WA• Advanced Pharma Inc.

Phenylephrine HCl (Advanced Pharma) – Labeling Error (2018)

Labeling: Label Error on Declared Strength: Label incorrectly lists concentration as "10 mcg per mL" rather than the correct concentration of "100 mcg per mL".

Class IHigh

FDANov 29, 2018IN, NM, OH +1 more• Advanced Pharma Inc.